title: Early-stage loss of dopamine uptake-site binding in MPTP-treated monkeys.
authors.affiliation: Massachusetts Institute of Technology, Department of Brain and Cognitive Sciences, Cambridge 02139.
authors.forename: A M
authors.initials: AM
authors.lastname: Graybiel
authors.forename: R
authors.initials: R
authors.lastname: Moratalla
authors.forename: B
authors.initials: B
authors.lastname: Quinn
authors.forename: L E
authors.initials: LE
authors.lastname: DeLanney
authors.forename: I
authors.initials: I
authors.lastname: Irwin
authors.forename: J W
authors.initials: JW
authors.lastname: Langston
mesh_terms: D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine / Q000494:pharmacology*; D000818:Animals; D001345:Autoradiography; D001931:Brain Mapping; D002421:Caudate Nucleus / Q000187:drug effects / Q000473:pathology; D003342:Corpus Striatum / Q000187:drug effects* / Q000473:pathology; D004298:Dopamine / Q000502:physiology*; D004305:Dose-Response Relationship, Drug; D007279:Injections, Subcutaneous; D008454:Mazindol / Q000493:pharmacokinetics; D009434:Neural Pathways / Q000187:drug effects / Q000473:pathology; D010302:Parkinson Disease, Secondary / Q000139:chemically induced* / Q000473:pathology; D011699:Putamen / Q000187:drug effects / Q000473:pathology; D011954:Receptors, Dopamine / Q000187:drug effects* / Q000648:ultrastructure; D012453:Saimiri; D013378:Substantia Nigra / Q000187:drug effects* / Q000473:pathology
chemical_list: D011954:Receptors, Dopamine; D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; D008454:Mazindol; D004298:Dopamine